Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca to present next wave of science in respiratory disease at ERS International Congress
-
Qtrilmet recommended for approval in EU by CHMP for the treatment of type-2 diabetes
-
AstraZeneca amends collaboration with Ironwood for Linzess in China
-
AstraZeneca redefines cancer treatment with practice-changing data at ESMO 2019
-
FDA grants Fast Track designation for Farxiga in heart failure
-
Imfinzi is first immunotherapy to show both significant survival benefit and improved, durable responses in extensive-stage small cell lung cancer
-
Tagrisso approved in China as a 1st-line treatment for EGFR-mutated non-small cell lung cancer
-
Brilinta reduced the risk of cardiovascular events in patients with coronary artery disease and type-2 diabetes in Phase III THEMIS trial
-
Detailed results from Phase III DAPA-HF trial showed Farxiga significantly reduced both the incidence of cardiovascular death and the worsening of heart failure
-
AstraZeneca to present data at ESC Congress 2019 that potentially redefine the treatment of heart failure
Latest articles and press releases
All of our latest press releases and articles are available to explore
